Abingworth as of Sept. 30, 2018
Portfolio Holdings for Abingworth
Abingworth holds 16 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 32.6 | $55M | 1.2M | 44.34 | |
| Sientra | 31.2 | $53M | 2.2M | 23.88 | |
| Verona Pharma Plc ads (VRNA) | 6.7 | $11M | 902k | 12.50 | |
| Paratek Pharmaceuticals | 6.0 | $10M | 1.0M | 9.65 | |
| Obseva Sa | 4.7 | $7.9M | 440k | 18.04 | |
| Chiasma | 4.5 | $7.5M | 2.1M | 3.60 | |
| Proteon Therapeutics | 2.3 | $3.8M | 2.0M | 1.90 | |
| Adaptimmune Therapeutics (ADAP) | 2.0 | $3.4M | 250k | 13.56 | |
| Cymabay Therapeutics | 1.8 | $3.0M | 273k | 11.07 | |
| Ultragenyx Pharmaceutical (RARE) | 1.7 | $2.9M | 38k | 76.38 | |
| Cellectis S A (CLLS) | 1.7 | $2.8M | 100k | 28.23 | |
| Aurinia Pharmaceuticals (AUPH) | 1.6 | $2.7M | 400k | 6.63 | |
| Sierra Oncology | 1.5 | $2.5M | 1.4M | 1.70 | |
| AVEO Pharmaceuticals | 0.8 | $1.3M | 400k | 3.29 | |
| Immune Design | 0.7 | $1.2M | 352k | 3.40 | |
| Histogenics Corp Cmn | 0.3 | $471k | 889k | 0.53 |
